Target intelligence / Profile preview

Immunoglobulin kappa variable 3-25 (IGKV3-25)

Target
IGKV3-25
Molecular classification
Immunoglobulin variable region, Antibody fragment, Immunoglobulin superfamily
01

Overview

Immunoglobulin kappa variable 3-25 is a variable region segment of the immunoglobulin kappa light chain gene family. It encodes the antigen-binding portion of the light chain of antibodies, created through V(D)J recombination in B cells, and is critical for the diversity of antigen recognition in humoral immunity[1][3]. IGKV3-25 is not a receptor, enzyme, or direct therapeutic target; rather, it is a genetic element whose products are components of antibodies produced by B lymphocytes. Variable segments like IGKV3-25 are important in research for understanding immune diversity and antibody repertoire, but they are not considered stand-alone therapeutic targets[1][3][4]. If you intended a full-length immunoglobulin (antibody) as a therapeutic target (e.g., CD20, PD-1), please specify further, as variable regions are subcomponents—not themselves drug or biologic targets.

Other names
IGKV3-25Immunoglobulin kappa variable region 3-25
02

Biological functions

Antigen recognitionHumoral immune response
03

Disease associations

Other (No evidence for direct involvement in disease. Immunoglobulin variable regions are not direct therapeutic targets but may be studied in context of autoimmune, infectious, or oncological diseases.)

Beyond the preview

Go deeper on Immunoglobulin kappa variable 3-25 (IGKV3-25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 3-25 (IGKV3-25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call